Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.
2.

Therapeutic Antiviral Effect of the Nucleic Acid Polymer REP 2055 against Persistent Duck Hepatitis B Virus Infection.

Noordeen F, Scougall CA, Grosse A, Qiao Q, Ajilian BB, Reaiche-Miller G, Finnie J, Werner M, Broering R, Schlaak JF, Vaillant A, Jilbert AR.

PLoS One. 2015 Nov 11;10(11):e0140909. doi: 10.1371/journal.pone.0140909. eCollection 2015.

3.

Conceptual models for the initiation of hepatitis B virus-associated hepatocellular carcinoma.

Tu T, Budzinska MA, Shackel NA, Jilbert AR.

Liver Int. 2015 Jul;35(7):1786-800. doi: 10.1111/liv.12773. Epub 2015 Feb 9. Review.

PMID:
25640596
4.

Clonal expansion of hepatocytes with a selective advantage occurs during all stages of chronic hepatitis B virus infection.

Tu T, Mason WS, Clouston AD, Shackel NA, McCaughan GW, Yeh MM, Schiff ER, Ruszkiewicz AR, Chen JW, Harley HA, Stroeher UH, Jilbert AR.

J Viral Hepat. 2015 Sep;22(9):737-53. doi: 10.1111/jvh.12380. Epub 2015 Jan 26.

PMID:
25619231
5.

Duck hepatitis B virus covalently closed circular DNA appears to survive hepatocyte mitosis in the growing liver.

Reaiche-Miller GY, Thorpe M, Low HC, Qiao Q, Scougall CA, Mason WS, Litwin S, Jilbert AR.

Virology. 2013 Nov;446(1-2):357-64. doi: 10.1016/j.virol.2013.08.014. Epub 2013 Sep 13.

6.

Nucleic acid polymers prevent the establishment of duck hepatitis B virus infection in vivo.

Noordeen F, Vaillant A, Jilbert AR.

Antimicrob Agents Chemother. 2013 Nov;57(11):5299-306. doi: 10.1128/AAC.01005-13. Epub 2013 Aug 12.

7.

Nucleic acid polymers inhibit duck hepatitis B virus infection in vitro.

Noordeen F, Vaillant A, Jilbert AR.

Antimicrob Agents Chemother. 2013 Nov;57(11):5291-8. doi: 10.1128/AAC.01003-13. Epub 2013 Aug 12.

8.

The development of persistent duck hepatitis B virus infection can be prevented using antiviral therapy combined with DNA or recombinant fowlpoxvirus vaccines.

Feng F, Teoh CQ, Qiao Q, Boyle D, Jilbert AR.

Vaccine. 2010 Oct 28;28(46):7436-43. doi: 10.1016/j.vaccine.2010.08.091. Epub 2010 Sep 15.

PMID:
20833122
9.

The persistence in the liver of residual duck hepatitis B virus covalently closed circular DNA is not dependent upon new viral DNA synthesis.

Reaiche GY, Le Mire MF, Mason WS, Jilbert AR.

Virology. 2010 Oct 25;406(2):286-92. doi: 10.1016/j.virol.2010.07.013. Epub 2010 Aug 12.

10.

Detection of clonally expanded hepatocytes in chimpanzees with chronic hepatitis B virus infection.

Mason WS, Low HC, Xu C, Aldrich CE, Scougall CA, Grosse A, Clouston A, Chavez D, Litwin S, Peri S, Jilbert AR, Lanford RE.

J Virol. 2009 Sep;83(17):8396-408. doi: 10.1128/JVI.00700-09. Epub 2009 Jun 17.

11.

The amount of hepatocyte turnover that occurred during resolution of transient hepadnavirus infections was lower when virus replication was inhibited with entecavir.

Mason WS, Xu C, Low HC, Saputelli J, Aldrich CE, Scougall C, Grosse A, Colonno R, Litwin S, Jilbert AR.

J Virol. 2009 Feb;83(4):1778-89. doi: 10.1128/JVI.01587-08. Epub 2008 Dec 10.

12.

Pre-P is a secreted glycoprotein encoded as an N-terminal extension of the duck hepatitis B virus polymerase gene.

Cao F, Scougall CA, Jilbert AR, Tavis JE.

J Virol. 2009 Feb;83(3):1368-78. doi: 10.1128/JVI.01263-08. Epub 2008 Nov 12.

13.

Immune selection during chronic hepadnavirus infection.

Mason WS, Litwin S, Jilbert AR.

Hepatol Int. 2008 Mar;2(1):3-16. doi: 10.1007/s12072-007-9024-3. Epub 2007 Dec 14.

14.

Antiviral therapy with entecavir combined with post-exposure "prime-boost" vaccination eliminates duck hepatitis B virus-infected hepatocytes and prevents the development of persistent infection.

Miller DS, Boyle D, Feng F, Reaiche GY, Kotlarski I, Colonno R, Jilbert AR.

Virology. 2008 Apr 10;373(2):329-41. doi: 10.1016/j.virol.2007.11.032. Epub 2008 Jan 18.

15.

Hepatocyte turnover in transient and chronic hepadnavirus infections.

Mason WS, Litwin S, Xu C, Jilbert AR.

J Viral Hepat. 2007 Nov;14 Suppl 1:22-8. Review.

PMID:
17958639
16.

The liver of woodchucks chronically infected with the woodchuck hepatitis virus contains foci of virus core antigen-negative hepatocytes with both altered and normal morphology.

Xu C, Yamamoto T, Zhou T, Aldrich CE, Frank K, Cullen JM, Jilbert AR, Mason WS.

Virology. 2007 Mar 15;359(2):283-94. Epub 2006 Oct 31.

18.
19.
20.
21.

Effect of antiviral treatment with entecavir on age- and dose-related outcomes of duck hepatitis B virus infection.

Foster WK, Miller DS, Scougall CA, Kotlarski I, Colonno RJ, Jilbert AR.

J Virol. 2005 May;79(9):5819-32.

22.

Identification and characterization of avihepadnaviruses isolated from exotic anseriformes maintained in captivity.

Guo H, Mason WS, Aldrich CE, Saputelli JR, Miller DS, Jilbert AR, Newbold JE.

J Virol. 2005 Mar;79(5):2729-42.

23.

Clonal expansion of hepatocytes during chronic woodchuck hepatitis virus infection.

Mason WS, Jilbert AR, Summers J.

Proc Natl Acad Sci U S A. 2005 Jan 25;102(4):1139-44. Epub 2005 Jan 18.

24.

Adenovirus-based gene therapy during clevudine treatment of woodchucks chronically infected with woodchuck hepatitis virus.

Zhu Y, Cullen JM, Aldrich CE, Saputelli J, Miller D, Seeger C, Mason WS, Jilbert AR.

Virology. 2004 Sep 15;327(1):26-40.

25.

Molecular characterization of duck hepatitis B virus isolates from South African ducks.

Mangisa NP, Smuts HE, Kramvis A, Linley CW, Skelton M, Tucker TJ, De La M Hall P, Kahn D, Jilbert AR, Kew MC.

Virus Genes. 2004 Mar;28(2):179-86.

PMID:
14976417
26.

Studying host immune responses against duck hepatitis B virus infection.

Miller DS, Bertram EM, Scougall CA, Kotlarski I, Jilbert AR.

Methods Mol Med. 2004;96:3-25. No abstract available.

PMID:
14762255
27.
28.

Hepatocyte turnover during resolution of a transient hepadnaviral infection.

Summers J, Jilbert AR, Yang W, Aldrich CE, Saputelli J, Litwin S, Toll E, Mason WS.

Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11652-9. Epub 2003 Sep 19.

29.

Entecavir therapy combined with DNA vaccination for persistent duck hepatitis B virus infection.

Foster WK, Miller DS, Marion PL, Colonno RJ, Kotlarski I, Jilbert AR.

Antimicrob Agents Chemother. 2003 Aug;47(8):2624-35.

30.

Kinetics of hepadnavirus loss from the liver during inhibition of viral DNA synthesis.

Zhu Y, Yamamoto T, Cullen J, Saputelli J, Aldrich CE, Miller DS, Litwin S, Furman PA, Jilbert AR, Mason WS.

J Virol. 2001 Jan;75(1):311-22.

31.

Structural and functional homology between duck and chicken interferon-gamma.

Huang A, Scougall CA, Lowenthal JW, Jilbert AR, Kotlarski I.

Dev Comp Immunol. 2001 Jan;25(1):55-68.

PMID:
10980320
32.

Immune responses to duck hepatitis B virus infection.

Jilbert AR, Kotlarski I.

Dev Comp Immunol. 2000 Mar-Apr;24(2-3):285-302. Review.

PMID:
10717294
33.

In situ hybridization protocols for detection of viral DNA using radioactive and nonradioactive DNA probes.

Jilbert AR.

Methods Mol Biol. 2000;123:177-93. No abstract available.

PMID:
10547770
34.

Characterisation of duck thrombocytes.

Bertram EM, Jilbert AR, Kotlarski I.

Res Vet Sci. 1998 May-Jun;64(3):267-70.

PMID:
9690617
35.

Lamivudine therapy of WHV-infected woodchucks.

Mason WS, Cullen J, Moraleda G, Saputelli J, Aldrich CE, Miller DS, Tennant B, Frick L, Averett D, Condreay LD, Jilbert AR.

Virology. 1998 May 25;245(1):18-32.

36.

Characterization of age- and dose-related outcomes of duck hepatitis B virus infection.

Jilbert AR, Botten JA, Miller DS, Bertram EM, Hall PM, Kotlarski J, Burrell CJ.

Virology. 1998 May 10;244(2):273-82.

37.

Protective efficacy of DNA vaccines against duck hepatitis B virus infection.

Triyatni M, Jilbert AR, Qiao M, Miller DS, Burrell CJ.

J Virol. 1998 Jan;72(1):84-94.

38.
39.

An homologous in vitro assay to detect lymphokines released by PHA-activated duck peripheral blood lymphocytes and spleen cells.

Bertram EM, Jilbert AR, Kotlarski I.

Vet Immunol Immunopathol. 1997 May;56(1-2):163-74.

PMID:
9220589
40.

Kinetics of duck hepatitis B virus infection following low dose virus inoculation: one virus DNA genome is infectious in neonatal ducks.

Jilbert AR, Miller DS, Scougall CA, Turnbull H, Burrell CJ.

Virology. 1996 Dec 15;226(2):338-45.

41.

Identification of duck T lymphocytes using an anti-human T cell (CD3) antiserum.

Bertram EM, Wilkinson RG, Lee BA, Jilbert AR, Kotlarski I.

Vet Immunol Immunopathol. 1996 Jun 1;51(3-4):353-63.

PMID:
8792572
42.

Woodchuck hepatitis virus infections: very rapid recovery after a prolonged viremia and infection of virtually every hepatocyte.

Kajino K, Jilbert AR, Saputelli J, Aldrich CE, Cullen J, Mason WS.

J Virol. 1994 Sep;68(9):5792-803.

43.

Postnatal psychosis: a patient's experience with comments by the consulting psychiatrist.

Jilbert AR, Williams AE.

Aust Coll Midwives Inc J. 1994 Jun;7(2):26-30.

PMID:
8018031
44.

Inhibition of duck hepatitis B virus replication by hypericin.

Moraleda G, Wu TT, Jilbert AR, Aldrich CE, Condreay LD, Larsen SH, Tang JC, Colacino JM, Mason WS.

Antiviral Res. 1993 Mar;20(3):235-47.

PMID:
8470884
45.

Rapid resolution of duck hepatitis B virus infections occurs after massive hepatocellular involvement.

Jilbert AR, Wu TT, England JM, Hall PM, Carp NZ, O'Connell AP, Mason WS.

J Virol. 1992 Mar;66(3):1377-88.

46.

A technique for liver biopsy performed in Pekin ducks using anesthesia with Telazol.

Carp NZ, Saputelli J, Halbherr TC, Mason WS, Jilbert AR.

Lab Anim Sci. 1991 Oct;41(5):474-5.

PMID:
1666151
47.

Cell culture model systems to study HDV expression, replication and pathogenesis.

Gowans EJ, Macnaughton TB, Jilbert AR, Burrell CJ.

Prog Clin Biol Res. 1991;364:299-308.

PMID:
2020706
48.

Characterization of a subgenomic HDV-specific poly(A)+ RNA species isolated from human hepatoma cells supporting HDV RNA replication.

Jilbert AR, Gowans EJ, Macnaughton TB, Burrell CJ.

Prog Clin Biol Res. 1991;364:309-14. No abstract available.

PMID:
1708506
49.

Serological analysis of duck hepatitis B virus infection.

Qiao M, Gowans EJ, Bailey SE, Jilbert AR, Burrell CJ.

Virus Res. 1990 Aug;17(1):3-13.

PMID:
2220071
50.

Hepatitis delta virus RNA, protein synthesis and associated cytotoxicity in a stably transfected cell line.

Macnaughton TB, Gowans EJ, Jilbert AR, Burrell CJ.

Virology. 1990 Aug;177(2):692-8.

PMID:
2164731

Supplemental Content

Loading ...
Support Center